Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005730 | nucleolus | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043228 | non-membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4H4A5
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 59 | 63 | PF00656 | 0.534 |
CLV_NRD_NRD_1 | 138 | 140 | PF00675 | 0.272 |
CLV_NRD_NRD_1 | 195 | 197 | PF00675 | 0.605 |
CLV_NRD_NRD_1 | 59 | 61 | PF00675 | 0.481 |
CLV_NRD_NRD_1 | 68 | 70 | PF00675 | 0.500 |
CLV_PCSK_FUR_1 | 134 | 138 | PF00082 | 0.272 |
CLV_PCSK_FUR_1 | 196 | 200 | PF00082 | 0.441 |
CLV_PCSK_FUR_1 | 65 | 69 | PF00082 | 0.589 |
CLV_PCSK_KEX2_1 | 136 | 138 | PF00082 | 0.272 |
CLV_PCSK_KEX2_1 | 190 | 192 | PF00082 | 0.510 |
CLV_PCSK_KEX2_1 | 194 | 196 | PF00082 | 0.498 |
CLV_PCSK_KEX2_1 | 198 | 200 | PF00082 | 0.507 |
CLV_PCSK_KEX2_1 | 67 | 69 | PF00082 | 0.542 |
CLV_PCSK_PC1ET2_1 | 136 | 138 | PF00082 | 0.272 |
CLV_PCSK_PC1ET2_1 | 190 | 192 | PF00082 | 0.510 |
CLV_PCSK_PC1ET2_1 | 194 | 196 | PF00082 | 0.498 |
CLV_PCSK_PC1ET2_1 | 198 | 200 | PF00082 | 0.507 |
CLV_PCSK_PC1ET2_1 | 67 | 69 | PF00082 | 0.575 |
CLV_PCSK_PC7_1 | 134 | 140 | PF00082 | 0.272 |
CLV_PCSK_PC7_1 | 191 | 197 | PF00082 | 0.423 |
CLV_PCSK_SKI1_1 | 39 | 43 | PF00082 | 0.493 |
DEG_SPOP_SBC_1 | 40 | 44 | PF00917 | 0.477 |
DOC_PP4_FxxP_1 | 102 | 105 | PF00568 | 0.306 |
DOC_USP7_UBL2_3 | 163 | 167 | PF12436 | 0.383 |
DOC_USP7_UBL2_3 | 186 | 190 | PF12436 | 0.315 |
DOC_USP7_UBL2_3 | 194 | 198 | PF12436 | 0.522 |
LIG_14-3-3_CanoR_1 | 13 | 19 | PF00244 | 0.440 |
LIG_14-3-3_CanoR_1 | 138 | 144 | PF00244 | 0.273 |
LIG_14-3-3_CanoR_1 | 22 | 27 | PF00244 | 0.516 |
LIG_14-3-3_CanoR_1 | 51 | 55 | PF00244 | 0.490 |
LIG_BRCT_BRCA1_1 | 43 | 47 | PF00533 | 0.479 |
LIG_deltaCOP1_diTrp_1 | 145 | 154 | PF00928 | 0.416 |
LIG_FHA_2 | 41 | 47 | PF00498 | 0.538 |
LIG_LIR_Gen_1 | 120 | 129 | PF02991 | 0.275 |
LIG_LIR_Nem_3 | 120 | 126 | PF02991 | 0.275 |
LIG_PDZ_Class_3 | 197 | 202 | PF00595 | 0.671 |
LIG_Pex14_2 | 143 | 147 | PF04695 | 0.272 |
LIG_PTB_Apo_2 | 148 | 155 | PF02174 | 0.416 |
LIG_SH2_STAT5 | 128 | 131 | PF00017 | 0.332 |
LIG_SUMO_SIM_anti_2 | 93 | 98 | PF11976 | 0.272 |
MOD_CK1_1 | 16 | 22 | PF00069 | 0.497 |
MOD_CK1_1 | 25 | 31 | PF00069 | 0.639 |
MOD_CK2_1 | 84 | 90 | PF00069 | 0.263 |
MOD_GlcNHglycan | 18 | 21 | PF01048 | 0.655 |
MOD_GlcNHglycan | 43 | 46 | PF01048 | 0.679 |
MOD_GlcNHglycan | 48 | 51 | PF01048 | 0.635 |
MOD_GlcNHglycan | 86 | 89 | PF01048 | 0.465 |
MOD_GSK3_1 | 157 | 164 | PF00069 | 0.195 |
MOD_GSK3_1 | 190 | 197 | PF00069 | 0.614 |
MOD_GSK3_1 | 22 | 29 | PF00069 | 0.483 |
MOD_GSK3_1 | 46 | 53 | PF00069 | 0.492 |
MOD_GSK3_1 | 9 | 16 | PF00069 | 0.477 |
MOD_NEK2_1 | 14 | 19 | PF00069 | 0.471 |
MOD_NEK2_1 | 24 | 29 | PF00069 | 0.572 |
MOD_PIKK_1 | 7 | 13 | PF00454 | 0.449 |
MOD_PIKK_1 | 73 | 79 | PF00454 | 0.272 |
MOD_PKA_1 | 190 | 196 | PF00069 | 0.512 |
MOD_PKA_2 | 190 | 196 | PF00069 | 0.649 |
MOD_PKA_2 | 50 | 56 | PF00069 | 0.495 |
MOD_PKB_1 | 137 | 145 | PF00069 | 0.272 |
MOD_SUMO_rev_2 | 53 | 63 | PF00179 | 0.492 |
MOD_SUMO_rev_2 | 66 | 74 | PF00179 | 0.598 |
TRG_ENDOCYTIC_2 | 21 | 24 | PF00928 | 0.431 |
TRG_ENDOCYTIC_2 | 99 | 102 | PF00928 | 0.332 |
TRG_ER_diArg_1 | 137 | 139 | PF00400 | 0.310 |
TRG_NLS_Bipartite_1 | 178 | 198 | PF00514 | 0.311 |
TRG_NLS_Bipartite_1 | 67 | 86 | PF00514 | 0.370 |
TRG_NLS_MonoCore_2 | 135 | 140 | PF00514 | 0.272 |
TRG_NLS_MonoExtC_3 | 193 | 198 | PF00514 | 0.532 |
TRG_NLS_MonoExtN_4 | 134 | 140 | PF00514 | 0.272 |
TRG_NLS_MonoExtN_4 | 191 | 198 | PF00514 | 0.513 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PDK2 | Leptomonas seymouri | 78% | 100% |
A0A0S4JBE6 | Bodo saltans | 51% | 100% |
A0A1X0P5L4 | Trypanosomatidae | 57% | 100% |
A0A3R7RI11 | Trypanosoma rangeli | 57% | 100% |
A0A3S7WYT4 | Leishmania donovani | 82% | 100% |
A4I180 | Leishmania infantum | 82% | 100% |
D0A5G5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 55% | 100% |
E9AXB4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 84% | 100% |
Q4QA58 | Leishmania major | 80% | 100% |
V5B7R5 | Trypanosoma cruzi | 56% | 100% |